Adj. EBITDA of USD 21.1m (Arctic: USD 23.8m, Cons.: USD 23.9m)
Catch below exp. as krill appeared late in Q4, record start to 2021
Reiterates Adj. EBITDA target of USD 200m in 2024, OSE listing in April 21
We expect to lower our 21 estimates by ~ 5-10%
16 Feb 2021
Q4/20 slightly below expectations
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
Q4/20 slightly below expectations
Aker BioMarine ASA (AKBM:OSL) | 0 0 0.0%
- Published:
16 Feb 2021 -
Author:
Thomas Lorck | Axel Jacobsen -
Pages:
6 -
Adj. EBITDA of USD 21.1m (Arctic: USD 23.8m, Cons.: USD 23.9m)
Catch below exp. as krill appeared late in Q4, record start to 2021
Reiterates Adj. EBITDA target of USD 200m in 2024, OSE listing in April 21
We expect to lower our 21 estimates by ~ 5-10%